Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
OPIANT PHARMACEUTICALS, INC. | Director, 10%+ Owner | Common Stock, par value $0.001 per share | 0 | $20.00 | Mar 2, 2023 | Direct | |
OPIANT PHARMACEUTICALS, INC. | Director, 10%+ Owner | Common Stock | 0 | $20.00 | Mar 2, 2023 | Indirect | |
OPIANT PHARMACEUTICALS, INC. | Director, 10%+ Owner | Options | 0 | Mar 2, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
OPNT | OPIANT PHARMACEUTICALS, INC. | Mar 2, 2023 | 6 | -$1.8M | 4 | Mar 3, 2023 | Director, 10%+ Owner |
OPNT | OPIANT PHARMACEUTICALS, INC. | Jun 13, 2022 | 3 | -$149K | 4 | Jun 15, 2022 | Director, 10%+ Owner |
OPNT | OPIANT PHARMACEUTICALS, INC. | Jun 9, 2022 | 1 | -$96.7K | 4 | Jun 13, 2022 | Director, 10%+ Owner |
OPNT | OPIANT PHARMACEUTICALS, INC. | Jun 6, 2022 | 2 | -$110K | 4 | Jun 8, 2022 | Director, 10%+ Owner |
OPNT | OPIANT PHARMACEUTICALS, INC. | Jun 2, 2022 | 2 | -$275K | 4 | Jun 6, 2022 | Director, 10%+ Owner |
OPNT | OPIANT PHARMACEUTICALS, INC. | Aug 23, 2021 | 9 | -$1.61M | 4 | Aug 25, 2021 | Director, 10%+ Owner |